EUnetCCC - The European Comprehensive Cancer Centre Network
Funding Organization: Unione Europea (EU4Health Programme 2021–2027)
Principal Investigator: Dott.ssa Miceli Rosalba
Start date:
End date:
Main Facility: Biostatistica per la Ricerca Clinica
“EUnetCCC Joint Action is co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them. The authors are not responsible for any further and future use of the report by third parties and third-party translations.”
Comprehensive Cancer Centres (CCCs) are at the forefront of cancer research, treatment, and education. Through a multidisciplinary approach, they ensure that patients benefit from the latest scientific advances throughout the entire care pathway, from early detection and innovative therapies to survivorship and follow-up care.
The European Comprehensive Cancer Centre (EU CCC) Network was established to create a harmonised and integrated approach to cancer care across Europe. Built on the principles of excellence, collaboration, and innovation, the network aims to ensure that all patients, regardless of where they live, have access to high-quality cancer care.
These pillars are corner stones for the Joint Action EUnetCCC:
- Recognising that advanced cancer centres will be the driving force and hub for realising this vision, both locally, nationally, and across Europe.
- Success is two-fold. It depends on close collaboration between CCCs and their European networks. At the same time, it relies on strong alignment with national healthcare systems and cancer policies.
- To be considered comprehensive, a cancer centre must integrate prevention, treatment, research, and education, while sharing a unified vision of quality standards.
- Cross-border collaboration between CCCs is a critical infrastructure to promote equity and accelerate joint progress in cancer care in Europe.
Coordinator: Institut National du Cancer Gip (INCA)
Number of partners: 163
Total Project cost: € 112 012 503.62
Project number: 101183407
Participant countries: Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Ukraine, Moldova, Romania
Principal Investigator Dr. Miceli Rosalba
Struttura Principale: Biostatistics for Clinical Research
Simple Structure
Last update: 17/09/2026